Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Claritev (CTEV) EPS (Weighted Average and Diluted) (2019 - 2026)

Claritev's quarterly EPS (Weighted Average and Diluted) came in at -$4.41 in Q1 2026, down 0.68% year-on-year from -$4.44 in Q1 2025, and up 9.63% quarter-over-quarter from -$4.88 in Q4 2025.

Claritev has reported EPS (Weighted Average and Diluted) for 8 years, with the latest figure at -$4.41 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 0.68% year-over-year to -$4.41; the trailing twelve-month figure through Mar 2026 stood at -$17.33 (up 76.23% YoY), and the FY2025 full-year result was -$17.3, up 83.03% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 stood at -$4.41, up from -$4.88 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.07 in Q1 2022, with the low at -$35.78 in Q2 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$7.53, with a median of -$3.81 recorded in 2025.
  • Year-over-year, EPS (Weighted Average and Diluted) jumped 128.57% in 2022 and tumbled 10242254.57% in 2024.
  • Tracing CTEV's EPS (Weighted Average and Diluted) over 5 years: stood at -$1.02 in 2022, then slumped by 90.2% to -$1.94 in 2023, then tumbled by 337.63% to -$8.49 in 2024, then soared by 42.52% to -$4.88 in 2025, then increased by 9.63% to -$4.41 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$4.41 (Q1 2026), -$4.88 (Q4 2025), and -$4.23 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 1.48
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.67
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.82
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.41
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.10
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.22
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -0.10
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 0.02
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.25
10 Claritev 456.62 Mn 428.62 Mn 175.60 Mn -4.41

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4.41
Dec 31, 2025 -4.88
Sep 30, 2025 -4.23
Jun 30, 2025 -3.81
Mar 31, 2025 -4.38
Dec 31, 2024 -8.49
Sep 30, 2024 -24.25
Jun 30, 2024 -35.78
Mar 31, 2024 -33.40
Dec 31, 2023 -1.94
Sep 30, 2023 -1.49
Jun 30, 2023 -0.06
Mar 31, 2023 0.00
Dec 31, 2022 -1.02
Sep 30, 2022 0.03
Jun 30, 2022 0.02
Mar 31, 2022 0.07
Dec 31, 2021 0.04
Sep 30, 2021 0.12
Jun 30, 2021 -0.07
Mar 31, 2021 0.07
Dec 31, 2020 -0.27
Sep 30, 2020 -0.69
Jun 30, 2020 -0.14
Mar 31, 2020 -0.01
Dec 31, 2019 0.25